{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:35:23Z","timestamp":1790145323548,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100009859","name":"Geoffrey Beene Cancer Research Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009859","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Erdheim-Chester Disease Global Alliance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13023-016-0490-3","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T07:52:46Z","timestamp":1470124366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease"],"prefix":"10.1186","volume":"11","author":[{"given":"Eli L.","family":"Diamond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaios","family":"Hatzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raajit","family":"Rampal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei I.","family":"Holodny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"issue":"4","key":"490_CR1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","volume":"124","author":"EL Diamond","year":"2014","unstructured":"Diamond EL, Dagna L, Hyman DM, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124(4):483\u201392.","journal-title":"Blood"},{"issue":"10","key":"490_CR2","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2010-10-313510","volume":"117","author":"L Arnaud","year":"2011","unstructured":"Arnaud L, Gorochov G, Charlotte F, et al. Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients. Blood. 2011;117(10):2783\u201390.","journal-title":"Blood"},{"key":"490_CR3","first-page":"1","volume":"21","author":"J Haroche","year":"2015","unstructured":"Haroche J, Cohen-Aubart F, Charlotte F, et al. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm. Expert Rev Clin Immunol. 2015;21:1\u201310.","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"490_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","volume":"6","author":"EL Diamond","year":"2016","unstructured":"Diamond EL, Durham BH, Haroche J, et al. Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov. 2016;6(2):154\u201365.","journal-title":"Cancer Discov"},{"issue":"2","key":"490_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9(2):179\u201394.","journal-title":"Neuroimage"},{"issue":"2","key":"490_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/nimg.1998.0396","volume":"9","author":"B Fischl","year":"1999","unstructured":"Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage. 1999;9(2):195\u2013207.","journal-title":"Neuroimage"},{"issue":"3","key":"490_CR7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.neuroimage.2006.05.050","volume":"32","author":"V Napadow","year":"2006","unstructured":"Napadow V, Dhond R, Kennedy D, Hui KK, Makris N. Automated brainstem co-registration (ABC) for MRI. Neuroimage. 2006;32(3):1113\u20139.","journal-title":"Neuroimage"},{"issue":"11","key":"490_CR8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00005072-199711000-00005","volume":"56","author":"H Adle-Biassette","year":"1997","unstructured":"Adle-Biassette H, Chetritt J, Bergemer-Fouquet AM, Wechsler J, Mussini JM, Gray F. Pathology of the central nervous system in Chester-Erdheim disease: report of three cases. J Neuropathol Exp Neurol. 1997;56(11):1207\u201316.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"490_CR9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jpeds.2010.03.001","volume":"156","author":"N Grois","year":"2010","unstructured":"Grois N, Fahrner B, Arceci RJ, et al. Central nervous system disease in Langerhans cell histiocytosis. J Pediatr. 2010;156(6):873\u201381. 81 e1.","journal-title":"J Pediatr"},{"issue":"1","key":"490_CR10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pbc.20760","volume":"48","author":"E Mittheisz","year":"2007","unstructured":"Mittheisz E, Seidl R, Prayer D, et al. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007;48(1):50\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"490_CR11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JAD-2012-111832","volume":"31","author":"CH Kim","year":"2012","unstructured":"Kim CH, Seo SW, Kim GH, et al. Cortical thinning in subcortical vascular dementia with negative 11C-PiB PET. J Alzheimer\u2019s Dis. 2012;31(2):315\u201323.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"7","key":"490_CR12","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.neurobiolaging.2010.12.003","volume":"33","author":"SW Seo","year":"2012","unstructured":"Seo SW, Lee JM, Im K, et al. Cortical thinning related to periventricular and deep white matter hyperintensities. Neurobiol Aging. 2012;33(7):1156\u201367.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"490_CR13","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.neurobiolaging.2015.06.027","volume":"36","author":"JD Gispert","year":"2015","unstructured":"Gispert JD, Rami L, Sanchez-Benavides G, et al. Nonlinear cerebral atrophy patterns across the Alzheimer\u2019s disease continuum: impact of APOE4 genotype. Neurobiol Aging. 2015;36(10):2687\u2013701.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"490_CR14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1176\/ajp.152.7.987","volume":"152","author":"EH Aylward","year":"1995","unstructured":"Aylward EH, Brettschneider PD, McArthur JC, et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry. 1995;152(7):987\u201394.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"490_CR15","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/mds.22488","volume":"24","author":"C Sanchez-Castaneda","year":"2009","unstructured":"Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, et al. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson\u2019s disease with dementia. Mov Disord. 2009;24(12):1740\u20136.","journal-title":"Mov Disord"},{"issue":"12","key":"490_CR16","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1002\/art.22280","volume":"54","author":"A Stoppacciaro","year":"2006","unstructured":"Stoppacciaro A, Ferrarini M, Salmaggi C, et al. Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis. Arthritis Rheum. 2006;54(12):4018\u201322.","journal-title":"Arthritis Rheum"},{"issue":"28","key":"490_CR17","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1200\/JCO.2012.41.9911","volume":"30","author":"L Dagna","year":"2012","unstructured":"Dagna L, Corti A, Langheim S, et al. Tumor necrosis factor alpha as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab. J Clin Oncol. 2012;30(28):e286\u201390.","journal-title":"J Clin Oncol"},{"key":"490_CR18","doi-asserted-by":"crossref","unstructured":"Ferrero E, Belloni D, Corti A, Doglioni C, Dagna L, Ferrarini M. TNF-alpha in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab. Rheumatology. 2014;53(1):198-200.","DOI":"10.1093\/rheumatology\/ket246"},{"issue":"3","key":"490_CR19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-010-0722-x","volume":"120","author":"VH Perry","year":"2010","unstructured":"Perry VH. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol. 2010;120(3):277\u201386.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"490_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000079408","volume":"11","author":"BN Lee","year":"2004","unstructured":"Lee BN, Dantzer R, Langley KE, et al. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation. 2004;11(5):279\u201392.","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"490_CR21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46\u201356.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"490_CR22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroimage.2006.02.051","volume":"32","author":"X Han","year":"2006","unstructured":"Han X, Jovicich J, Salat D, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage. 2006;32(1):180\u201394.","journal-title":"Neuroimage"},{"issue":"1-2","key":"490_CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2005.03.006","volume":"233","author":"R Zivadinov","year":"2005","unstructured":"Zivadinov R. Steroids and brain atrophy in multiple sclerosis. J Neurol Sci. 2005;233(1-2):73\u201381.","journal-title":"J Neurol Sci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-016-0490-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T22:05:34Z","timestamp":1568239534000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-016-0490-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["490"],"URL":"https:\/\/doi.org\/10.1186\/s13023-016-0490-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]},"article-number":"109"}}